145 related articles for article (PubMed ID: 22860991)
1. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.
Crooke A; Huete-Toral F; Martínez-Águila A; Colligris B; Pintor J
Expert Opin Drug Discov; 2012 Oct; 7(10):989-1001. PubMed ID: 22860991
[TBL] [Abstract][Full Text] [Related]
2. Melatonin receptors in the eye: location, second messengers and role in ocular physiology.
Alarma-Estrany P; Pintor J
Pharmacol Ther; 2007 Mar; 113(3):507-22. PubMed ID: 17229466
[TBL] [Abstract][Full Text] [Related]
3. Melatonin in the eye: implications for glaucoma.
Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP; Rosenstein RE
Exp Eye Res; 2007 Jun; 84(6):1021-30. PubMed ID: 17174303
[TBL] [Abstract][Full Text] [Related]
4. Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues.
Wiechmann AF; Summers JA
Prog Retin Eye Res; 2008 Mar; 27(2):137-60. PubMed ID: 18316227
[TBL] [Abstract][Full Text] [Related]
5. Role of melatonin in the eye and ocular dysfunctions.
Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP
Vis Neurosci; 2006; 23(6):853-62. PubMed ID: 17266777
[TBL] [Abstract][Full Text] [Related]
6. The role and therapeutic potential of melatonin in age-related ocular diseases.
Crooke A; Huete-Toral F; Colligris B; Pintor J
J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28658514
[TBL] [Abstract][Full Text] [Related]
7. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis.
Rosenstein RE; Pandi-Perumal SR; Srinivasan V; Spence DW; Brown GM; Cardinali DP
J Pineal Res; 2010 Aug; 49(1):1-13. PubMed ID: 20492443
[TBL] [Abstract][Full Text] [Related]
8. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
[TBL] [Abstract][Full Text] [Related]
9. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of melatonin receptor agonists.
Paulis L; Simko F; Laudon M
Expert Opin Investig Drugs; 2012 Nov; 21(11):1661-78. PubMed ID: 22916799
[TBL] [Abstract][Full Text] [Related]
11. Light, dark, and melatonin: emerging evidence for the importance of melatonin in ocular physiology.
Brennan R; Jan JE; Lyons CJ
Eye (Lond); 2007 Jul; 21(7):901-8. PubMed ID: 17001324
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of melatonin in experimental free radical-related ocular diseases.
Siu AW; Maldonado M; Sanchez-Hidalgo M; Tan DX; Reiter RJ
J Pineal Res; 2006 Mar; 40(2):101-9. PubMed ID: 16441546
[TBL] [Abstract][Full Text] [Related]
13. Localization of Mel1b melatonin receptor-like immunoreactivity in ocular tissues of Xenopus laevis.
Wiechmann AF; Udin SB; Summers Rada JA
Exp Eye Res; 2004 Oct; 79(4):585-94. PubMed ID: 15381042
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of melatonin ligands.
Delagrange P; Boutin JA
Chronobiol Int; 2006; 23(1-2):413-8. PubMed ID: 16687314
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. Effects of intraperitoneal vitamin E, melatonin and aprotinin on leptin expression in the guinea pig eye during experimental uveitis.
Kükner A; Colakoğlu N; Serin D; Alagöz G; Celebi S; Kükner AS
Acta Ophthalmol Scand; 2006 Feb; 84(1):54-61. PubMed ID: 16445440
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Myles ME; Neumann DM; Hill JM
Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
[TBL] [Abstract][Full Text] [Related]
18. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye.
Bernstein PS; Khachik F; Carvalho LS; Muir GJ; Zhao DY; Katz NB
Exp Eye Res; 2001 Mar; 72(3):215-23. PubMed ID: 11180970
[TBL] [Abstract][Full Text] [Related]
19. Melatonin: Unveiling the functions and implications in ocular health.
Zhang J; Zhou H; Cai Y; Yoshida S; Li Y; Zhou Y
Pharmacol Res; 2024 Jul; 205():107253. PubMed ID: 38862072
[TBL] [Abstract][Full Text] [Related]
20. Melatonin in cardiovascular disease.
Dominguez-Rodriguez A
Expert Opin Investig Drugs; 2012 Nov; 21(11):1593-6. PubMed ID: 22916801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
